FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study
New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude trimming enhance patient experience and comfort
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study
New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude trimming enhance patient experience and comfort
Read more at globenewswire.com